May 3, 2026

@michaelokun

Stem cells and Parkinson’s: hope, hype, and hard truths. Stem cells are special cells that can develop into many different cell types, including dopamine producing brain cells. Stamper, Bulstrode and Barker describe in a new paper in the Journal of Parkinson’s Disease how stem cell therapies for Parkinson’s disease have evolved, and where science meets misconception. Key points: - Dopamine cell therapy aims to replace lost dopamine-producing neurons, however it is not a cure because it does not stop the underlying disease process. - Early and current clinical trials show modest and variable benefits, w/ ongoing challenges in cell survival, delivery and integration into brain circuits. - Safety signals so far are encouraging, however long term risks, optimal patient selection and dosing strategies remain to be fully defined. My take: This is a thoughtful and grounded review. I had the honor of interviewing Roger Barker for our book the Parkinson's Plan. Stem cell therapy for Parkinson’s disease is real science, not science fiction, however it is also not ready to meet the expectations that frequently circulate online. Progress is steady, and the field is learning from each step forward and each misstep. Here are 5 points that resonated w/ me: 1- Stem cell therapies are designed to repair dopamine systems, not to cure Parkinson’s disease. 2- Results so far show signals of benefit, however they are inconsistent and not yet transformative. 3- Safety appears reassuring in early trials, however long term follow up is essential before broad adoption. 4- Not every patient will be an ideal candidate, and timing of therapy will likely matter. 5- The future may depend on improving delivery, survival of transplanted cells and integrating therapies w/ precision medicine approaches. https://journals.sagepub.com/doi/full/10.1177/1877718X261434672 #parkinson #stemcells #michaelokun #fixelinstitute